跳至主要内容
临床试验/NL-OMON52628
NL-OMON52628招募中不适用

Optimizing diagnosis of splanchnic vein thrombosis with MR Direct Thrombus Imaging. - Rhea study

eids Universitair Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with confirmed acute SVT; definitions provided in paragraph 4.2 in
  • the Rhea study protocol (Cases, group 1)
  • - Patients with confirmed non-symptomatic chronic SVT, defined by incident SVT
  • with chronic thrombi on 2 serial imaging tests with at least 3 months interval
  • (controls, group 2)
  • - Aged 18 years and older
  • - Willing and able to give informed consent

排除标准

  • - MRI contra-indication (including but not limited to a cardiac pacemaker or
  • subcutaneous defibrillator; vascular clips in the cerebral vessels; metal
  • splinter in the eye, a hearing aid that cannot be removed; a neurostimulator
  • that cannot be removed; a hydrocephalus pump)
  • - A medical condition, associated illness or co-morbid circumstances that
  • precludes completion of the study procedures (MRI and 90-day follow-up
  • assessment), including but not limited to life-expectancy less than 3 months,
  • inability to lie flat, morbid obesity preventing use of MR and claustrophobia.
  • - Patients with decompensated liver disease with Child-Pugh class C cirrhosis
  • (since MRDTI evaluation will be inadequate in these patients)
  • - Patients with suspected tumour thrombus

研究者

相似试验